New Delhi: US President Donald Trump hinted at a possible retaliation if India does not lift its ban on the export of Hydroxychloroquine — the anti-malaria drug that Trump has repeatedly touted as a “game-changer” in the fight against COVID-19.
Speaking from White House during the coronavirus taskforce briefing, Trump said that he would be “surprised” if New Delhi doesn’t send Hydroxychloroquine.
Last week, Trump said he sought the help of PM Narendra Modi during a call with him and requested India to release the amount of Hydroxychloroquine ordered by the US.
Hydroxychloroquine is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other diseases.
Reiterating that for many years, India has been taking advantage of the US on trade, Trump said, “I didn’t hear that was his (Modi’s) decision. I know that he stopped it for other countries I spoke to him yesterday, very very good talk, and we’ll see whether or not that stays I wouldn’t be surprised if he would you know because India’s does very well with the United States.”
“So, I would be surprised if that were his decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course, there may be retaliation. Why wouldn’t there be?” Trump added.
- Assam: This social entrepreneur is building communities with tea and art
- Nepal: PM Deuba vows to protect, implement statute on Constitution Day
- Taliban-run Kabul municipality to female workers: Stay home
- WhileWeWonder: The duo speak about Xewali and their musical journey
- Girish And The Chronicles signs with Italian label Frontiers Music
- Backdoor entry in colleges should stop: Delhi High Court